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Lipid peroxidation in human proteinuric disease. and loss of function ultimately requiring renal replace-
Background. While metabolically generated oxidants are ment therapy [1–3]. In spite of progress in establishing
produced locally in experimental glomerular diseases, little is the inflammatory, toxic, metabolic, and genetic pathwaysstill known of their significance and the respective scavenger
involved, as well as identification of a variety of newsystems in human glomerular diseases.
glomerular cell-specific molecules, little is still known ofMethods. Here we studied kidneys from patients with con-
genital nephrotic syndrome of the Finnish type (CNF), a human the exact molecular mechanisms maintaining the glomer-
model disease of isolated proteinuria. Expression of specific ular filtration barrier.
mRNAs for a major antioxidant system against lipoperoxi- We have previously studied the mechanisms of glo-dation [phospholipid hydroperoxide glutathione peroxidase
merular permeability in a human model disease of pro-(PHGPx)] and for mitochondrial proteins were studied in
teinuria, the congenital nephrotic syndrome of the Finn-Northern blotting together with analysis of PHGPx in semi-
quantitative reverse transcription-polymerase chain reaction ish type (CNF). In this autosomal recessive disease
(RT-PCR). The respective proteins and lipoperoxide (LPO) manifesting in the newborn with massive proteinuria, no
adducts malonyldialdehyde (MDA) and 4-hydroxynonenal symptoms are found from other organ systems [4–6].(4-HNE) were analyzed in immunohistochemistry.
The exact molecular mechanisms of the glomerular per-Results. PHGPx and the mitochondrially encoded subunits
meability failure in CNF remain to be determined. Ma¨n-of cytochrome-c-oxidase were distinctly down-regulated within
the glomeruli of CNF kidneys. These changes were confirmed nikko¨ et al have excluded defects of major matrix compo-
in semiquantitative RT-PCR. Increases of lipoperoxidation nents of the glomerular basement membranes (GBMs)
products MDA and 4-HNE were constantly found in the glo-
as well as some developmentally regulated genes in CNFmeruli of CNF. In agreement with findings in CNF, similar
[7, 8] and have recently established the gene defect of thisresults were obtained in biopsies from other human glomerular
diseases. syndrome by cloning a new gene, NPHS1, responsible for
Conclusions. These findings suggest that local mitochondrial this syndrome [9]. The functions of NPHS1 and its pro-
damage initiates LPO, which then causes deposition of the tein product nephrin in the kidney as well as in other
cytotoxic LPO products in glomeruli, as seen especially in CNF
tissues are not yet known. However, we [10] and otherskidneys. Together with down-regulation of the local antioxi-
[11] have shown that nephrin localizes at the filtrationdant protection, these may be important pathophysiologic
mechanisms in human glomerular disease. slit area of podocytes.
Although metabolically generated oxidants, including
reactive oxygen species (ROS) and lipoperoxides (LPOs),
Proteinuria is an unspecific symptom of kidney dam- can be found as an epiphenomenon in many diseases
age associated with glomerular disease regardless of the [12–14], there is plenty of recent evidence that especially
etiology. The extent of proteinuria correlates with the ROS are distinctly associated with various types of exper-
morphologic severity of glomerular damage, and persis- imental glomerulonephritis [15–19]. Lipid peroxidation,
tent proteinuria can lead to irreversible renal scarring mainly perturbing membrane and intracellular lipids,
was recently introduced as a major pathogenetic mecha-
nism in Heymann nephritis, the experimental model of
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membranous glomerulonephritis [20]. Lipid peroxida-4-hydroxynoneal, malonyldialdehyde, phospholipid hydroperoxide glu-
tathione peroxidase, glomerular disease. tion products were found under experimental conditions
in glomeruli especially at the GBM. In Western blottingReceived for publication January 7, 2000
of the extracellular matrix, LPO adducts were shown toand in revised form April 27, 2000
Accepted for publication August 10, 2000 bind in vitro and supposedly damage primarily type IV
collagen in the rat kidney [21]. Inhibition of lipid peroxi-Ó 2001 by the International Society of Nephrology
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dation with probucol, a lipophilic chain-breaking antioxi- and immediately processed for RNA isolation [22]. Sam-
ples of cortical tissue were also processed for histochem-dant, resulted in 80% reduction of proteinuria in Hey-
mann nephritis [20, 21]. Together, these results strongly istry and immunohistochemistry as previously described
[22, 23].suggest a pathogenic role for lipid peroxidation in pro-
teinuria, but the exact mechanisms involved are yet to Kidney biopsy samples, diagnosed as membranous
glomerulonephritis (N 5 6) and diabetic nephropathybe defined.
This study examined the role of lipid peroxidation in (age of patients .18 years, N 5 6), were obtained for
routine diagnostic procedures. Both groups showed pro-the kidneys of patients with congenital nephrotic syn-
drome as a human model disease of proteinuria. For this teinuria exceeding 6 g/24 hours (6.2 to 15.6 g/24 hours)
The biopsies were snap frozen and stored in liquid nitro-purpose, we analyzed some key markers and enzymes
involved in lipid peroxidation by Northern blotting, sem- gen until used.
For normal controls, cadaver kidneys (N 5 2, ages ofiquantitative reverse transcription-polymerase chain re-
action (RT-PCR), and immunohistochemistry. Biopsies donors 12 and 18 years) unsuitable for transplantation
because of vascular anatomical reasons (Department offrom other human glomerular diseases were studied in
parallel. Surgery, University of Helsinki) were used and, for the
younger donors (N 5 2, ages 3 and 5 years) a normalThe results show a distinct increase of local lipid perox-
idation products in all of the tissue samples studied, as pole of a kidney removed because of Wilms’ tumor was
used. These were processed as described previously inreflected by the increase in the lipid peroxidation prod-
ucts 4-hydroxynonenal (4-HNE) and malonyldialdehyde this article for CNF, with an exception that the cadaver
kidneys were perfused with Ringer’s buffer solution via(MDA), especially in the glomerular epithelial cells.
Simultaneously, the local defense against lipid peroxi- the renal artery.
dation provided by the enzyme phospholipid hydro-
Immunofluorescence microscopyperoxide glutathione peroxidase (PHGPx) was seen to
decrease, as shown by immunohistochemistry and semi- To study the presence and distribution of lipid peroxi-
dation products 4-HNE, MDA as well as the PHGPx,quantitative RT-PCR. We propose that a local mitochon-
drial damage also verified here, followed by an increase superoxide dismutase and catalase, frozen sections of
normals and CNF kidney, and kidney biopsy samplesin tissue damaging lipoperoxidation and failure to pro-
tect cells effectively against lipoperoxidation may be im- of patients from membranous glomerulonephritis and
diabetic nephropathy were cut at 3 to 4 mm, fixed inportant pathophysiologic features of human proteinuric
disease. acetone at 2208C for five minutes, and washed in phos-
phate-buffered saline (PBS). Thereafter, polyclonal anti-
bodies against 4-HNE, MDA [24], PHGPx [25] (Cu/Zn)
METHODS
superoxide dismutase (Serotec, Oxford, UK), and cata-
Normal and nephrotic human kidneys lase (Serotec) were flooded over sections for 30 minutes.
After washing, the tissue sections were further incubatedRenal tissues from CNF patients were obtained at
nephrectomies performed according to an established with rat anti-rabbit IgG (Boehringer, Mannheim, Ger-
many) coupled with fluorescein isothiocyanate (FITC).treatment protocol. This includes daily albumin infu-
sions, aggressive parenteral nutrition, and as the weight An Olympus OX50 microscope equipped with an epi-
illuminator and a filter system for FITC fluorescence wasof 8 to 9 kg is achieved (at an age of 6 to 12 months),
bilateral nephrectomy [5]. Further treatment included used for microscopy.
peritoneal dialysis and finally renal transplantation. Di-
RNA isolationagnosis of CNF (N 5 6) was based on the typical clinical
picture at birth (placental weight .40% of the weight Total glomerular RNA was isolated using the guanidi-
nium thiocyanate-cesium chloride method from the CNFof the newborn, edema, massive proteinuria), with exclu-
sion of other types of congenital nephrosis, and later by and control kidneys as described earlier [26].
the typical pathology at nephrectomy [5]. Serum albumin
Northern blottingand protein concentrations were characteristically low,
and all patients had overt proteinuria [6]. The complete Total RNA (30 mg RNA/lane) from CNF and normal
human cortex samples was electrophoresed and trans-laboratory findings of urine and serum of the CNF pa-
tients have been reported earlier [5, 6]. ferred to nylon membranes. Membranes were ultraviolet
cross-linked (Stratalinker; Stratagene, La Jolla, CA,All of the procedures were approved by the ethical
committee of the University of Helsinki (Helsinki, Fin- USA) and hybridized as described earlier [22]. To con-
trol the total RNA content and lack of degradation inland).
The kidneys at nephrectomy were kept at 08C, and the analyzed preparations, the blots were rehybridized
with a human b-actin probe. For autoradiography, theglomeruli were isolated by the sieving method [22, 23]
Solin et al: Lipid peroxidation in proteinuric disease 483
Fig. 1. Immunostaining of congenital ne-
phrotic syndrome of the Finnish type (CNF)
patient kidneys (A and B) and normal human
kidney cortex (C ) with anti–4-hydroxyno-
nenal (anti-4-HNE) antibodies. Strong, patchy
reactivity at areas facing the urinary space in
glomeruli is obvious in CNF kidneys (A and
B, arrows), whereas faint background reactiv-
ity is seen in normal kidney (C). Bar 10 mm
(A and C) and 3 mm (B).
filters were exposed on Fuji Bas IIIS Imaging Plates, and glomeruli. For this purpose, total RNA from isolated
glomerular fractions was used as previously describedthe expression was quantitated using a phosphoimager
[27]. Oligo(dT)-primer was used in reverse transcription,and accompanying MacBAS software (Fuji Photo Film
and oligonucleotide primers specific for PHGPx wereCo., Tokyo, Japan).
used in PCR reactions. The semiquantitation is basedTo detect expression of genes for the mitochondrial
on the amount of housekeeping (b-actin, GAPDH) am-respiratory chain complex IV subunits, cytochrome-c-
plification product [27].oxidase (COX I, COX IV) as markers for mitochondrial
function and the main protective enzyme (PHGPx), we
used specific cDNA probes in Northern analysis. Probe
RESULTS
for PHGPx was produced by RT-PCR using random
Lipid peroxidation productshexamer primers in reverse transcription, and PHGPx-
specific primers were used in PCR. Specific primers were Immunohistochemistry of CNF cortical kidney sam-
ples revealed a consistent deposition of both 4-HNEbased on the mRNA sequence of human PHGPx (Gen-
bank accession number X71973). For 59 primer (nt 220 (Fig. 1 A, B) and MDA (Fig. 2 a, b) within glomeruli,
whereas only traces of glomerular reactivity could beto 238), we used 59-AGG ACA TCG ACG GGC ACA
T and for 39 primer (nt 642 to 661) 59-GGC AGG TCC seen within control kidneys (Figs. 1C and 2e). 4-HNE
and MDA were seen as finely granular dense reactivity atTTC TCT ATC AC. The amplified PCR fragment was
cloned into the pGEM-T vector (Promega, Madison, the glomerular basement membranes and preferentially
within podocytes, as determined by their localizationWI, USA). The authenticity of the cloned fragment was
verified by DNA sequencing (DNA sequencing kit, ver- next to the urinary space (Figs. 1B and 2b). Similarly,
in biopsy samples of human membranous (N 5 6) andsion 2.0; United States Biochemicals, Cleveland, OH,
USA). minimal change (N 5 6) patients, 4-HNE and MDA
(Fig. 2 c, d) were seen within glomeruli, particularly atTo reveal transcript levels of COX I, a plasmid B36
containing a 363 bp long cDNA fragment of COX I gene the GBM and mesangium.
and plasmid pCOX4 containing a 682 bp COX IV cDNA
PHGPx immunohistochemistryfragment (courtesy of Dr. M.I. Lomax) were used.
In line with previous studies, a heavy, finely granular
Semiquantitative RT-PCR staining for the lipoperoxidation protective enzyme
We also determined the level of PHGPx transcription PHGPx was observed in immunohistochemistry within
podocytes in the control kidney (Fig. 3a). In all CNFby semiquantitative RT-PCR from the RNA of isolated
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Fig. 2. Immunostaining of CNF patient kid-
neys (a and b), biopsy sample of membranous
glomerulonephritis (c), diabetic nephropathy
(d ), and normal human kidney (e) with anti-
MDA antibodies. Reactivity is seen in appar-
ent podocytes (arrows in a and b) but also in
the mesangium and at the basement mem-
branes (b–d). (Bar 5 10 mm for a, c, and e;
and 3 mm for b and d).
Fig. 3. Reactivity of anti-phospholipid hydro-
peroxide glutathione peroxidase (anti-PHGPx)
antibodies in normal kidney cortex (a) and in
CNF kidney (b). Note the prominent reactiv-
ity in a podocyte-like pattern in (a, arrows)
with a decreased reactivity pattern in CNF
(b). Magnification 3260.
samples, glomerular reactivity of anti-PHGPx antibodies enzymes superoxide dismutase and catalase could be
seen within glomeruli of control or patient kidney biop-was decreased (Fig. 3b). No difference between the reac-
tivity of subcapsular and juxtamedullary glomeruli could sies (data not shown).
be observed. In contrast to CNF samples, no major de-
Northern blottingcrease in staining intensity of the patient biopsy samples
was seen. In agreement with previous results, no specific To detect changes in the RNA levels of PHGPx and,
as markers for mitochondrial function, COX subunitsglomerular reactivity for the predominant antioxidant
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was suggested (68% of the controls, P 5 0.24; no statisti-
cal significance).
DISCUSSION
Our study shows that a decrease of the mitochondrial
enzyme COX and a concomitant increase of tissue dam-
aging lipid peroxidation are associated with human glo-
merular disease. Furthermore, we show for the first time
a reciprocal local decrease of PHGPx, the major enzyme
system protecting against lipid peroxidation in glomeruli
[25, 28]. Together, our results suggest a causal relation-
ship between mitochondrial damage, LPO production,
and proteinuria.
The defective gene in CNF kidneys has recently been
Fig. 4. RNA expression levels of kidney cortical cytochrome-c-oxidase identified [9]. This gene codes for a new transmembrane
(COX) subunits encoded by the mitochondrial (COX I, COX II) and
protein, nephrin, with immunoglobulin-like sequencesnuclear genome (COX IV, COX VIb) in control human kidney
(NHK; ) and CNF ( ). When the values of the control kidneys are of cell adhesion molecules [9]. There is no direct evidence
normalized to 1.0, the values of the mitochondrially encoded compo- as yet that nephrin is involved in regulating the produc-
nents are decreased to 25.9 and 27.3% of the control (P , 0.001 for
tion of ROS. However, the genes, for example, forboth COX I and COX II vs. controls), whereas no significant change
in the nuclearly encoded components is seen. PHGPx as well as COX 6A, COX 7, NADH-hydro-
genase, and mitoribosomal proteins, locate in close
proximity of the nephrin gene in chromosome 19q13.1,
possibly indicating a cluster of genes in regulating mito-
Table 1. Transcript abundance in isolated glomeruli as determined
chondrial functions. It is noteworthy that Mandel, Ba-by RT-PCR and analyzed by densitometric scanning
callao, and Zampighi have shown that epithelial perme-
COX I Cyt b COX 7 PHGPx
ability is critically dependent on available adenosine
CNF 0.75 1.65 1.14 0.92 59-triphosphate (ATP) energy in vitro [29]. DisruptionNHG 4.02 2.66 1.59 1.41
of cellular ATP levels rapidly perturbs the actin networkCNF/NHG 0.19 0.62 0.72 0.65
important for maintaining specialized cellular architec-Signals are expressed relative to the level of b-actin expression and normalized
to the mean of the CNF samples (Fig. 5). Both for control and CNF samples, ture [30–32]. Thus, the common morphologic findings of
N 5 3. Abbreviations are in the Appendix. proteinuria, the flattening and retraction of podocyte
foot processes may be due to remodeling of the actin
skeleton in response to a decrease in ATP energy in
these cells. Interestingly, our recent results have clearlyencoded by the mitochondrial (COX I) and nuclear ge-
shown a strong decrease of all mitochondrial functions,nome (COX IV), Northern blotting analysis of total
including ATP formation in CNF glomeruli (Solin et al,RNA from cortical kidney was performed. The results
manuscript in preparation) [33].showed down-regulation of the mitochondrially encoded
The other human proteinuric diseases studied, adultCOX I and COX II to 25 and 26% of the controls (P ,
minimal change disease of unknown etiology and mem-0.001 for both), whereas the nuclearly encoded subunits
branotic nephropathy, showed similar accumulation ofCOX IV and COX VIIa were at 68 and 75% of controls,
the LPO adducts and a down-regulation of PHGPxrespectively (P 5 0.21 and 0.68, respectively; no statisti-
within glomeruli, which is suggestive of a general phe-cal significance; Fig. 4). No significant differences in
nomenon shared with other noninflammatory humanPHGPx from the RNA isolated from total kidney corti-
proteinuric diseases as they are in the experimentalcal tissue of CNF and normal kidneys were observed.
models.
RT-PCR Superoxide and hydroxyl radicals and hydrogen per-
oxide are the highly ROS mainly produced in mitochon-Northern analysis of total cortical kidney failed to
dria as unavoidable by-products of aerobic respirationreflect the mRNA abundance in glomeruli correctly as
[34]. In primary and secondary mitochondrial diseases,it composed only approximately 5% of the total cortical
an increase in ROS production is commonly seen thatvolume. Thus, to verify the glomerular expression level
subsequently leads to a decrease of energy productionof PHGPx message, a semiquantitative RT-PCR analysis
[34]. Luo et al have recently shown that this also causeswas used (Table 1 and Fig. 5). In agreement with protein
expression data in immunohistochemistry (Fig. 3), a simi- an increase in hydrogen peroxide levels and lipid peroxi-
dation products in human mitochondrial disease withlar down-regulation of the PHGPx-specific mRNA level
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Fig. 5. Semiquantitative RT-PCR of CNF and
normal human kidney glomeruli (NHG 1 and
NHG 2) with transcripts of mitochondrially
encoded cytochromes I (COX I) and cyto-
chrome b (CYT b), nuclearly encoded cyto-
chrome 7A (COX 7A) and phospholipid hy-
droperoxide glutathione peroxidase (PHGPx).
cDNAs were serially diluted to the range of
linear amplification (1021 to 1024); b-actin
expression was used to obtain comparable
cDNA concentrations in all samples. Note
the down-regulation of COX I, CYT b, and
PHGPx.
complex I deficiency [35]. Thus, regardless of the primary congenital nephrotic syndrome [37]. In line with other
results of this study, a decrease of the protective PHGPxdamage to mitochondria locally, lipoperoxidation ap-
could be shown by immunohistochemistry in the glomer-pears to be an important pathophysiologic effector mech-
ulus, where the changes appeared reciprocal to the in-anism involved. However, to date little is known of the
crease in the lipoperoxidation end-products MDA androle of mitochondrial functions and dysfunction in renal
4-HNE. In experimental models of proteinuria our re-disease. Indirect evidence suggests that glomerular per-
cent results show that mitochondrial damage, MDA andmeability in particular is highly dependent on the mainte-
4-HNE accumulation, as well as decrease of PHGPx arenance of energy balance [36]. It is also interesting that
found prior to the onset of proteinuria (Holtho¨fer et al,local LPO scavenger enzymes appear particularly impor-
manuscript submitted for publication). Together, thesetant for glomeruli, as evidenced by the abundant PHGPx
results suggest a strong causal relationship of mitochon-found in podocytes but not in other parts of the nephron.
drial damage and proteinuria.In fact, the only other major site of PHGPx expression
is in the testis [25]. Further studies are needed to eluci-
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